China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials
- Posted on May 29, 2026
- By South China Morning Post
- 0 Views
- 1 min read
China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.
